Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer vaccination progress.

Graham Pawelec1, Robert C Rees

  • 1University of Tuebingen Medical School, Center for Medical Research (ZMF), Germany. graham.pawelec@uni-tuebingen.de

Trends in Molecular Medicine
|December 10, 2002
PubMed
Summary
This summary is machine-generated.

New and recognized tumor antigens are key for cancer vaccination strategies. Discussions focused on activating CD8(+) and CD4(+) T-cell responses for effective cancer immunotherapy.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing fourteen consensus biomarkers of aging: epigenetic pace of aging as the strongest predictor of mortality in BASE-II.

Biomarker research·2026
Same author

Vδ1 T-cell subset appears to be responsive to PD-1 blockade therapy and is associated with survival in melanoma.

Journal for immunotherapy of cancer·2026
Same author

Aging-associated immune signature as a predictor of mortality in end-stage renal disease: results from the longitudinal iESRD study.

Immunity & ageing : I & A·2025
Same author

Open problems in ageing science: a roadmap for biogerontology.

GeroScience·2025
Same author

Clinical data-driven classification of pre-frailty reveals sex-specific patterns - Data from the Berlin Aging Study II (BASE-II).

Mechanisms of ageing and development·2025
Same author

Nonuniversality of inflammaging across human populations.

Nature aging·2025
Same journal

Targeting amino acid metabolism in hepatocellular carcinoma.

Trends in molecular medicine·2026
Same journal

Turning perfusion into repair through ferroptosis blockade.

Trends in molecular medicine·2026
Same journal

CaMKK2: A tumor stress-integration node.

Trends in molecular medicine·2026
Same journal

Precision gene editing: From proof-of-concept to curative therapies.

Trends in molecular medicine·2026
Same journal

Targeting ferroptosis halts graft deterioration in transplantation.

Trends in molecular medicine·2026
Same journal

Amyotrophic lateral sclerosis: A rare but aggressive adult-onset disease.

Trends in molecular medicine·2026
See all related articles

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • The 2nd 'Progress in Vaccination Against Cancer' meeting convened in July 2002.
  • The conference focused on advancing cancer vaccination strategies.

Framework:

  • Exploration of novel and established tumor antigens for therapeutic vaccine development.
  • Discussion on targeting both CD8(+) and CD4(+) T-cell responses.

Implementation:

  • Mechanisms of effector cell activation in the context of cancer vaccines.
  • Strategies for enhancing anti-tumor immune responses.

Implications:

  • Potential for improved cancer immunotherapy through targeted T-cell activation.
  • Advancement of vaccination approaches against various cancers.